2023年度宫颈癌防治现状与问题  

Cervical cancer prevention and current issues in 2023

作　　者：赵超[1] 李明珠[1] 邓浩[1] 魏丽惠[1] Zhao Chao;Li Mingzhu;Deng Hao;Wei Lihui(Department of Obstetrics and Gynecology,Peking University People's Hospital,Beijing 100044,China)

机构地区：[1]北京大学人民医院妇产科,北京100044

出　　处：《肿瘤综合治疗电子杂志》2024年第1期63-68,共6页Journal of Multidisciplinary Cancer Management(Electronic Version)

基　　金：国家重点研发计划(2021YFC2701202);北京市卫生健康科技成果和适宜技术推广项目(BHTPP2022008);北京大学人民医院研究与发展基金(RDL2021-04);北京大学人民医院研究与发展基金(RDL2022-34)。

摘　　要：宫颈癌是常见的女性恶性肿瘤,其主要致病原因是高危型人乳头瘤病毒(human papilloma virus,HPV)持续感染,通过为年轻女性接种HPV疫苗、在适龄女性中开展宫颈癌筛查、及时治疗宫颈癌与癌前病变等三级预防措施能够有效防控并最终实现消除宫颈癌。但目前宫颈癌防治中仍存在诸多问题,包括需要进一步推动适龄女性接种HPV疫苗、扩大筛查宫颈癌的覆盖率、宫颈癌治疗术式选择等。本文旨在总结2023年度宫颈癌防治现状和存在的问题。Cervical cancer is a common malignancy among women,primarily caused by persistent infection with high-risk human papilloma virus(HPV).The three-tier preventive measures,including HPV vaccination for young women,cervical cancer screening among eligible women,and timely treatment of cervical cancer and precancerous lesions,can effectively control and ultimately eliminate cervical cancer.However,the current cervical cancer prevention and control efforts still face numerous challenges.These include the need to further promote HPV vaccination among eligible women,expand the coverage of cervical cancer screening,and address challenges in the selection of treatment procedures for cervical cancer.This article aims to summarize the current status and existing issues in the prevention and control of cervical cancer in the year 2023.

关 键 词：宫颈癌 人乳头瘤病毒疫苗 筛查 宫颈癌治疗 

分 类 号：R737.33[医药卫生—肿瘤]